Page last updated: 2024-08-23

lodoxamide ethyl and Keratoconjunctivitis

lodoxamide ethyl has been researched along with Keratoconjunctivitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gonzalez-Gonzalez, JM; Macias-Rodriguez, Y; Rodriguez-Garcia, A	1

Other Studies

1 other study(ies) available for lodoxamide ethyl and Keratoconjunctivitis

Article	Year
Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis. International ophthalmology, 2018, Volume: 38, Issue:3 Topics: Administration, Topical; Adult; Aged; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Oxamic Acid; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult	2018

Article

Year

Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.

International ophthalmology, 2018, Volume: 38, Issue:3

Topics: Administration, Topical; Adult; Aged; Anti-Allergic Agents; Chronic Disease; Conjunctiva; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Keratoconjunctivitis; Limbus Corneae; Middle Aged; Ophthalmic Solutions; Oxamic Acid; Prospective Studies; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Young Adult

2018